Roche Diabetes Care India Launches its First Mass Market Glucometer

admin
admin
· 3 min read
Roche Diabetes Care India launches its first mass market glucometer

Roche Diabetes Care India, the country’s market leader in diabetes monitoring with Accu-Chek as its product brand, today announced the launch of its new glucometer Accu- Chek Instant S, which marks the entry of the organisation into the mass market segment in diabetes self- monitoring.

Speaking at the launch, Mr Sidhartha Roy, Managing Director of Roche Diabetes Care India said, “With India having the second highest population of people with diabetes (PwDs) in the world, we saw the need to take regular self-monitoring of diabetes to a larger population with a product that is not just affordable but is also easy to use. Self-monitoring of blood glucose (SMBG) is integral to diabetes management. We have seen in our experience that PwDs who practice SMBG and consult with their doctors regularly do not compromise on their lifestyle and face minimized risks of diabetes-related complications. Despite all the benefits of self-monitoring, only ~10%^ of PwDs own a blood glucose meter.

We notice that in India, PwDs deviate from their diabetes management routine often to keep up with their family and social commitments, and thus suffer glycaemic variability. However, they worry about their blood sugar fluctuation and either increase exercise or resort to diet restrictions, or even alter their medicine dosage to keep their blood sugar level under control. These efforts, they believe, have worked to bring their blood sugar levels back within range, without actually monitoring to check the reality.”

The new Accu-Chek Instant-S offers best-in-class accuracy and meets the latest global ISO 15197:2013 standards, at an affordable price of Rs 1099/-. Blood glucose testing with Instant-S is simplified, and the reading of results made easy. The meter has a 9-level target range indicator, which gives the PwD an indication of which range their reading falls in – normal, high and low – making for easy understanding of the reading.

Dr Varsha Khatry, Head – Medical and Scientific Affairs of Roche Diabetes Care India said, “During our interactions with PwDs we have found out that they perceive their body to be the best sensor of blood sugar fluctuations as they think their body gives symptoms (of weakness, tired feeling, increased urination, hunger etc.) whenever their blood glucose level fluctuates and thus they don’t really need to monitor it on a regular basis. However, managing diabetes on the basis of such assumptions can increase the risk of developing complications along with co-morbid conditions.”

The Accu-Chek Instant-S blood glucose monitoring system from Roche Diabetes Care India is designed to provide a truly effortless solution for PwDs in India. The meter does not require any set-up. The strip is inserted, a small blood sample applied and the value is shown in less than 4 seconds providing instant clarity. The intuitive target range indicator points to blue for above range, green for in range and red for below range. The meter can automatically synchronize all blood glucose results via USB to the Accu-Chek Connect Online Portal. The Accu-Chek Instant S blood glucose monitoring system offers reliable test results that exceed the new global ISO standards.

*IDF Atlas 2017: https://www.idf.org/our-network/regions-members/south-east-asia/members/94-india.html ^Self-Monitoring of Blood Glucose Systems in India, Frost & Sullivan Report 2010.

Read Next

MedGenome makes a majority investment in Siddhi Diagnostics & Research Centre  
News
May 20, 2026

MedGenome makes a majority investment in Siddhi Diagnostics & Research Centre  

MedGenome has joined hands with Siddhi Diagnostics & Research Centre (SDRC), a well-established diagnostic imaging service provider with a strong presence across Mumbai’s extended western suburbs. Founded in 1995, SDRC is led by Dr. Ajit Pungavkar and Dr. Sona Pungavkar. Dr. Ajit, a renowned sonologist with over 35 years of clinical experience, has devoted his […]
Article by: IMT News Desk
Lupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution
News
May 20, 2026

Lupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution

Global pharma major, Lupin Limited (Lupin), has announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Revefenacin Inhalation Solution, 175 mcg/3 mL Unit-Dose Vials. Lupin’s Revefenacin Inhalation Solution, 175 mcg/3 mL is bioequivalent to Mylan’s Yupelri® Inhalation Solution and indicated for […]
Article by: IMT News Desk
HCG opens new 132‑bed Bengaluru oncology facility with ₹129 crore investment
News
May 20, 2026

HCG opens new 132‑bed Bengaluru oncology facility with ₹129 crore investment

HealthCare Global Enterprises (HCG) has inaugurated a new 132‑bed comprehensive cancer care hospital in Hebbal/North Bengaluru, marking its third oncology facility in the city and expanding its network across Karnataka and India. Scale and investment The new Bengaluru facility represents a total investment of approximately ₹129 crore, funded through a mix of debt and internal […]
Article by: IMT News Desk
Hidden sugar patterns on the cell surface could enable early cancer detection, a new study shows
News
May 20, 2026

Hidden sugar patterns on the cell surface could enable early cancer detection, a new study shows

Scientists have uncovered a hidden “sugar code” on the surface of human cells that could revolutionize early‑stage cancer diagnosis, according to a new study published in Nature Nanotechnology by researchers at the Max Planck Institute for the Science of Light (MPL). What the study found Every human cell is coated with a thin layer of sugar molecules […]
Article by: IMT News Desk